查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1339159

研究机构非人灵长类动物临床前测试的全球市场、份额、规模、趋势和行业分析报告：按应用、地区和细分市场预测，2023-2032 年

Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market Share, Size, Trends, Industry Analysis Report, By Application (Infectious Disease, Immunological Disease, Cancer, Others) By Region; Segment Forecast, 2023 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的一项新研究，研究机构的非人灵长类动物临床前测试市场预计到 2032 年将达到 108,553,860 美元。该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

世界各地的研究机构对非人灵长类动物进行临床前测试是开发新药和疫苗的重要一步，CRO 为进行此类测试提供了经济高效的解决方案。基因组学和其他技术的最新进展提高了我们对非人灵长类动物生物学的理解，并促进了它们在临床前研究中的使用。然而，在研究中使用非人类灵长类动物仍然存在争议，开发非动物临床前测试的替代品的趋势日益明显。

基因组学和其他技术的最新进展加深了我们对非人类灵长类动物的生物学理解，并改善了用于转化研究的非人类灵长类动物模型的开发。这些进步也促进了非人灵长类动物在临床前测试中的使用，从而可以对新药和疫苗的安全性和有效性进行更全面的评估。

在北美 CRO 进行的非人灵长类动物临床前测试已成为药物开发的重要一步。新技术的整合和非人灵长类动物模型的升级用于转化研究，提高了非人灵长类临床前测试的准确性和有效性。

儘管由于伦理问题，在非临床研究中使用非人灵长类动物仍然存在争议，但 CRO 已经制定了严格的伦理准则和法规，以确保研究中使用的动物的福祉。我们遵守以下规定。此外，CRO 与监管机构密切合作，确保临床前研究在进行临床试验之前满足安全性和有效性要求。

欧洲 CRO 遵循严格的道德准则和法规，以确保动物福利，监管机构负责监督临床前研究的安全性和有效性。儘管在非临床研究中使用非人类灵长类动物仍然存在争议，但这些测试仍然是药物开发的重要步骤。

升级非人类灵长类动物模型用于转化研究的趋势日益明显，重点是使用具有特定疾病表型的非人灵长类动物。例如，开发了阿兹海默症、帕金森氏症和爱滋病毒感染的非人灵长类动物模型，以便更好地了解这些疾病的发病机制并测试新的治疗方法。

然而，在临床前测试中使用非人灵长类动物仍然存在争议，动物权利活动人士继续提出对动物福利的担忧。许多组织呼吁开发不涉及动物的临床前测试的替代方案。

全球市场研究报告重点介绍研究机构中的非人灵长类动物临床前测试

人们对使用基于非人灵长类动物（非人灵长类动物）的临床前研究进行研究的兴趣日益浓厚，是该领域增长的主要驱动力。

在北美，研究机构定期对非人灵长类动物进行临床前研究，以进行研究和开发以及跨中心鑑定具有特定表型的动物群体，并且这些研究正在显着增长。

目录

第 1 章 简介

第二章执行摘要

第三章研究方法论

第 4 章：全球研究机构非人类灵长类动物临床前测试的市场洞察

  • 研究机构中的非人灵长类动物临床前测试市场—产业概况
  • 研究机构非人灵长类临床前测试市场动态
    • 驱动因素和机遇
      • CRISPR 技术的创新导致非人类灵长类动物临床前试验的采用增加
      • 老年人口增加和目标疾病盛行率上升
    • 限制因素和挑战
      • 存在高昂的程序成本和模糊的监管框架
  • PESTLE分析
  • 价值链分析
  • 非人灵长类合约研究机构临床前研究产业趋势
  • COVID-19 感染的影响分析

第五章 全球研究机构非人灵长类临床前测试市场（按应用）

  • 主要发现
  • 介绍
  • 感染
  • 免疫性疾病
  • 癌症
  • 心血管疾病
  • 代谢性疾病
  • 遗传病
  • 呼吸系统疾病
  • 神经系统疾病
  • 与妇女有关的疾病
  • 其他

第六章 全球研究机构非人灵长类动物临床前测试市场（按地区）

  • 主要发现
  • 介绍
    • 2019-2032 年研究机构市场评估中的非人灵长类动物临床前测试（按地区）
  • 研究机构的非人灵长类临床前测试市场—北美
    • 北美：研究机构非人类灵长类动物临床前测试市场（按应用），2019-2032
    • 研究机构的非人灵长类动物临床前测试市场—美国
    • 研究机构的非人灵长类动物临床前测试市场—加拿大
  • 研究机构的非人灵长类动物临床前测试市场—欧洲
    • 欧洲：研究机构的非人类灵长类动物临床前测试市场，按应用划分，2019-2032
    • 研究机构的非人灵长类动物临床前测试市场—英国
    • 研究机构的非人灵长类动物临床前测试市场—法国
    • 研究机构的非人灵长类动物临床前测试市场—德国
    • 研究机构的非人灵长类动物临床前测试市场—义大利
    • 研究机构的非人灵长类动物临床前测试市场—西班牙
    • 研究机构的非人灵长类动物临床前测试市场—荷兰
    • 研究机构的非人灵长类动物临床前测试市场—奥地利
  • 研究机构的非人灵长类动物临床前测试市场 - 亚太地区
    • 亚太地区：研究机构中的非人灵长类动物临床前测试市场（按应用划分），2019-2032
    • 研究机构的非人灵长类临床前测试市场—中国
    • 研究机构的非人灵长类动物临床前测试市场—印度
    • 研究机构的非人灵长类动物临床前测试市场—马来西亚
    • 研究机构的非人灵长类动物临床前测试市场—日本
    • 研究机构的非人灵长类动物临床前测试市场—印度尼西亚
    • 研究机构的非人灵长类动物临床前测试市场—韩国
  • 研究机构的非人灵长类临床前测试市场—中东和非洲
    • 中东和非洲：研究机构非人类灵长类动物临床前测试市场（按应用），2019-2032
    • 研究机构的非人灵长类临床前测试市场—沙乌地阿拉伯
    • 研究机构的非人灵长类动物临床前测试市场—阿联酋
    • 研究机构的非人灵长类动物临床前测试市场—以色列
    • 研究机构的非人灵长类动物临床前测试市场—南非
  • 研究机构的非人灵长类动物临床前测试市场—拉丁美洲
    • 拉丁美洲：研究机构中的非人类灵长类动物临床前测试市场（按应用），2019-2032
    • 研究机构的非人灵长类动物临床前测试市场—墨西哥
    • 研究机构的非人灵长类动物临床前测试市场—巴西
    • 研究机构的非人灵长类动物临床前测试市场—阿根廷

第七章 竞争格局

  • 扩张和收购分析
    • 扩张
    • 获得
  • 伙伴关係/协作/协议/揭露

第八章公司简介

  • ABL, Inc
  • Applied BioCode Corporation
  • BioLegend, Inc
  • Exocell, Inc
  • HUREL Corporation
  • iQ Biosciences
  • Mabtech AB
Product Code: PM3539

The Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market size is expected to reach USD 1,08,553.86 thousands by 2032, according to a new study by Polaris Market Research. The report "Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market Share, Size, Trends, Industry Analysis Report, By Application (Infectious Disease, Immunological Disease, Cancer, Others) By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Global NHP pre-clinical studies are an essential step in the development of new drugs and vaccines, and CROs provide a cost-effective solution for conducting such studies. Recent advances in genomics and other technologies have improved our understanding of NHP biology and facilitated the use of NHPs in pre-clinical studies. However, the use of NHPs in research remains controversial, and there is a growing trend toward the development of alternative methods for pre-clinical testing that do not involve the use of animals.

Recent advances in genomics and other technologies have enabled a better understanding of NHP biology and improved the development of NHP models for translational research. These advances have also facilitated the use of NHPs in pre-clinical studies, allowing for a more comprehensive assessment of the safety and efficacy of new drugs and vaccines.

NHPs in pre-clinical studies at CROs in North America has become an essential step in drug development. The integration of new technologies and the upgradation of NHP models for translational research have improved the accuracy and efficacy of NHP pre-clinical studies.

While the use of NHPs in pre-clinical studies remains controversial due to ethical concerns, CROs adhere to strict ethical guidelines and regulations to ensure the welfare of animals used in research. Additionally, CROs work closely with regulatory agencies to ensure that the pre-clinical studies meet safety and efficacy requirements before advancing to clinical trials.

CROs in Europe follow strict ethical guidelines and regulations to ensure animal welfare and regulatory agencies oversee the safety and efficacy of pre-clinical studies. While the use of NHPs in pre-clinical studies remains controversial, these studies remain an essential step in drug development.

There is a growing trend towards the upgradation of NHP models for translational research, with more focus on using NHPs that have specific disease phenotypes. For example, NHP models of Alzheimer's disease, Parkinson's disease, and HIV infection have been developed to better understand the pathogenesis of these diseases and test new treatments.

However, the use of NHPs in pre-clinical studies remains controversial, and animal rights activists continue to voice their concerns about animal welfare. Many organizations have called for the development of alternative methods for pre-clinical testing that do not involve the use of animals.

Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market Report Highlights

The increasing interest in using non-human primate (NHP) based preclinical trials for research purposes has led to a significant boost in the growth of this segment.

North America witnesses the significant growth for the Non-Human Primate Pre-clinical studies at Contract Research Organizations periodically for the development and to identify cohorts of animals with specific phenotypes across centers.

The global players include: ABL, Inc., Applied BioCode Corporation, BioLegend, Inc., Exocell, Inc., HUREL Corporation, iQ Biosciences, and Mabtech AB, among others.

Polaris Market Research has segmented the Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market report based on Application and Region:

Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market,

Application Outlook (Revenue, USD Thousands, 2019-2032)

  • Infectious Disease
  • Immunological Disease
  • Cancer
  • Cardiovascular Disease
  • Metabolic Diseases
  • Genetic Disease
  • Respiratory Diseases
  • Neurological Disease
  • Female Related Diseases
  • Others

Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, Regional Outlook (Revenue - USD Thousands, 2019-2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market Insights

  • 4.1. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Industry Snapshot
  • 4.2. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Innovations in CRISPR technologies leading to increased adoption in NHP preclinical trials
      • 4.2.1.2. Rising Geriatric Population and Rising Prevalence of Target Diseases
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Procedure Costs and Presence of Ambiguous Regulatory Framework
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Value Chain Analysis
  • 4.6. Non-Human Primate Pre-clinical studies at Contract Research Organizations Industry trends
  • 4.7. COVID-19 Impact Analysis

5. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • 5.3. Infectious Disease
    • 5.3.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Infectious Disease, by Region, 2019-2032 (USD Million)
  • 5.4. Immunological Disease
    • 5.4.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Immunological Disease, by Region, 2019-2032 (USD Million)
  • 5.5. Cancer
    • 5.5.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Cancer, by Region, 2019-2032 (USD Million)
  • 5.6. Cardiovascular Disease
    • 5.6.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Cardiovascular Disease, by Region, 2019-2032 (USD Million)
  • 5.7. Metabolic Diseases
    • 5.7.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Metabolic Diseases, by Region, 2019-2032 (USD Million)
  • 5.8. Genetic Disease
    • 5.8.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Genetic Disease, by Region, 2019-2032 (USD Million)
  • 5.9. Respiratory Diseases
    • 5.9.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Respiratory Diseases, by Region, 2019-2032 (USD Million)
  • 5.10. Neurological Disease
    • 5.10.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Neurological Disease, by Region, 2019-2032 (USD Million)
  • 5.11. Female Related Diseases
    • 5.11.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Female Related Diseases, by Region, 2019-2032 (USD Million)
  • 5.12. Others
    • 5.12.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Geography

  • 6.1. Key findings
  • 6.2. Introduction
    • 6.2.1. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market Assessment, By Geography, 2019-2032 (USD Million)
  • 6.3. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - North America
    • 6.3.1. North America: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.3.2. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - U.S.
      • 6.3.2.1. U.S.: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.3.3. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Canada
      • 6.3.3.1. Canada: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • 6.4. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Europe
    • 6.4.1. Europe: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.4.2. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - UK
      • 6.4.2.1. UK: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.4.3. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - France
      • 6.4.3.1. France: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.4.4. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Germany
      • 6.4.4.1. Germany: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.4.5. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Italy
      • 6.4.5.1. Italy: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.4.6. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Spain
      • 6.4.6.1. Spain: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.4.7. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Netherlands
      • 6.4.7.1. Netherlands: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.4.8. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Austria
      • 6.4.8.1. Austria: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • 6.5. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Asia Pacific
    • 6.5.1. Asia Pacific: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.5.2. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - China
      • 6.5.2.1. China: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.5.3. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - India
      • 6.5.3.1. India: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.5.4. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Malaysia
      • 6.5.4.1. Malaysia: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.5.5. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Japan
      • 6.5.5.1. Japan: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.5.6. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Indonesia
      • 6.5.6.1. Indonesia: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.5.7. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - South Korea
      • 6.5.7.1. South Korea: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • 6.6. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Middle East & Africa
    • 6.6.1. Middle East & Africa: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.6.2. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Saudi Arabia
      • 6.6.2.1. Saudi Arabia: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.6.3. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - UAE
      • 6.6.3.1. UAE: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.6.4. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Israel
      • 6.6.4.1. Israel: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.6.5. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - South Africa
      • 6.6.5.1. South Africa: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • 6.7. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Latin America
    • 6.7.1. Latin America: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.7.2. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Mexico
      • 6.7.2.1. Mexico: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.7.3. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Brazil
      • 6.7.3.1. Brazil: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.7.4. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Argentina
      • 6.7.4.1. Argentina: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)

7. Competitive Landscape

  • 7.1. Expansion and Acquisition Analysis
    • 7.1.1. Expansion
    • 7.1.2. Acquisitions
  • 7.2. Partnerships/Collaborations/Agreements/Exhibitions

8. Company Profiles

  • 8.1. ABL, Inc
    • 8.1.1. Company Overview
    • 8.1.2. Financial Performance
    • 8.1.3. Product Benchmarking
    • 8.1.4. Recent Development
  • 8.2. Applied BioCode Corporation
    • 8.2.1. Company Overview
    • 8.2.2. Financial Performance
    • 8.2.3. Product Benchmarking
    • 8.2.4. Recent Development
  • 8.3. BioLegend, Inc
    • 8.3.1. Company Overview
    • 8.3.2. Financial Performance
    • 8.3.3. Product Benchmarking
    • 8.3.4. Recent Development
  • 8.4. Exocell, Inc
    • 8.4.1. Company Overview
    • 8.4.2. Financial Performance
    • 8.4.3. Product Benchmarking
    • 8.4.4. Recent Development
  • 8.5. HUREL Corporation
    • 8.5.1. Company Overview
    • 8.5.2. Financial Performance
    • 8.5.3. Product Benchmarking
    • 8.5.4. Recent Development
  • 8.6. iQ Biosciences
    • 8.6.1. Company Overview
    • 8.6.2. Financial Performance
    • 8.6.3. Product Benchmarking
    • 8.6.4. Recent Development
  • 8.7. Mabtech AB
    • 8.7.1. Company Overview
    • 8.7.2. Financial Performance
    • 8.7.3. Product Benchmarking
    • 8.7.4. Recent Development

List of Tables

  • Table 1 Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 2 Non-Human Primate Pre-clinical studies at Contract Research Organizations Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 3 North America: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 4 U.S.: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 5 Canada: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 6 Canada: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 7 Europe: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 8 Spain: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 9 Netherlands: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 10 Austria: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 11 Germany: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 12 Italy: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 13 France: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 14 Asia Pacific: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 15 China: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 16 Japan: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 17 India: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 18 Indonesia: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 19 South Korea: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 20 Malaysia: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 21 Latin America: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 22 Brazil: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 23 Mexico: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 24 Argentina: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 25 Middle East & Africa: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 26 South Africa: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 27 Israel: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 28 Saudi Arabia: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 29 UAE: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)

List of Figures

  • Figure 1 Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, 2019-2032 (USD Million)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by Application
  • Figure 7 Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2022 & 2032 (USD Million)
  • Figure 8 Non-Human Primate Pre-clinical studies at Contract Research Organizations Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 9 Strategic Analysis - Non-Human Primate Pre-clinical studies at Contract Research Organizations Market